Steps to Compliance: How Best to Prepare for Russia’s 2020 Pharma Regulations

Preparing for Russia’s regulation requirements might seem like a mountain to climb, but it’s a necessary journey for companies that want to remain in or enter the 10th largest pharmaceutical market in the world.

Drug-Eluting Devices: Delivering on Drug Delivery’s Combined Potential

Implantable drug-eluting devices (DEDs) have come a long way since 1938, when Finland approved a subcutaneously administered birth control device delivering levonorgestrel.

Particle analysis: Growing demand with biologics

The development and introduction of new biological drug substances has been on the rise, and so have the regulatory requirements placed on these often life-saving products.

Drivers behind Saudi Arabia’s forecast 10.74 $billion 2022 market explored ahead of CPhI MEA

The rapid growth of Saudi Arabia’s pharmaceutical market will be placed under the spotlight at the forthcoming CPhI MEA event, as the latest industry data reveals the Kingdom’s pharmaceutical market is expected to be valued at $10.74 billion by 2023.

Sharp’s Netherlands Facility Approved for Clinical Operations

Sharp – part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has received WDA and IMP licensing approvals to support..

Vineti and Cryoport Collaborate to Bring Integrated Solutions to the Global Regenerative Therapy Market

Vineti and Cryoport announced a commercial partnership designed to extend end-to-end delivery of cell therapies and gene therapies to a growing...